Scientist in lab coat examining specimen for RNAi research

RNAi Science

A living library of educational, scientific, and clinical resources

Alnylam Medical Information Hub

Overview

This website was created for US healthcare professionals to provide access to educational, clinical, and scientific information about Alnylam's therapeutic areas and the science of RNAi behind our FDA-approved products and clinical pipeline. Read on or connect with us to learn more about our science.

News & Latest Resources

Clinical Fellowship RFP – Transthyretin Cardiac Amyloidosis (ATTR Amyloidosis)

Alnylam is committed to supporting innovative, independent projects that address unmet educational needs and are intended to improve outcomes in the patient communities that it serves. Please refer to the Alnylam Grants and Giving Office for information on eligibility and other requirements for Alnylam’s Clinical Fellowship Program for academic year 2026-2027.

Posted: June 10, 2025

Keywords:

Alnylam

ATTRv Amyloidosis Hub

This Resource Center, provided by PRIME Education and supported by Alnylam Pharmaceuticals, contains downloadable resources and practical tools to support coordinated, multidisciplinary care and facilitate timely, comprehensive diagnostic evaluations for patients with ATTRv (also known as hATTR) amyloidosis.

Posted: August 05, 2024

Keywords:

amyloidosis

ATTRv

diagnosis

hATTR